Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs031220436Completed
Open-label, single-arm trial of ciprofloxacin. Primary endpoints: AUC0-24 and Cmax. Started Nov 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs031220436.